108 related articles for article (PubMed ID: 28604112)
1. Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey.
Peyrot M; Perez-Nieves M; Ivanova J; Cao D; Schmerold L; Kalirai S; Hadjiyianni I
Curr Med Res Opin; 2017 Oct; 33(10):1843-1851. PubMed ID: 28604112
[TBL] [Abstract][Full Text] [Related]
2. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey.
Perez-Nieves M; Ivanova JI; Hadjiyianni I; Zhao C; Cao D; Schmerold L; Kalirai S; King S; DeLozier AM; Birnbaum HG; Peyrot M
Curr Med Res Opin; 2017 Oct; 33(10):1833-1842. PubMed ID: 28604111
[TBL] [Abstract][Full Text] [Related]
3. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
[TBL] [Abstract][Full Text] [Related]
4. Basal insulin persistence in Brazilian participants with T2DM.
Franco DR; Perez-Nieves M; Ivanova JI; Cao D; Vaz MSC
Rev Assoc Med Bras (1992); 2019; 65(10):1254-1264. PubMed ID: 31721957
[TBL] [Abstract][Full Text] [Related]
5. Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from Germany.
Moennig E; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova J; Klask R
Exp Clin Endocrinol Diabetes; 2018 May; 126(5):287-297. PubMed ID: 28895642
[TBL] [Abstract][Full Text] [Related]
6. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
[TBL] [Abstract][Full Text] [Related]
7. Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.
Hadjiyianni I; Desai U; Suzuki S; Ivanova JI; Cao D; Kirson NY; Chida D; Enloe C; Birnbaum HG; Perez-Nieves M
Diabetes Ther; 2017 Feb; 8(1):149-166. PubMed ID: 27913984
[TBL] [Abstract][Full Text] [Related]
8. Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States.
Kalirai S; Ivanova JI; Perez-Nieves M; Stephenson JJ; Hadjiyianni I; Grabner M; Pollom RD; Geremakis C; Reed BL; Fisher L
Diabetes Metab Syndr Obes; 2020; 13():1023-1033. PubMed ID: 32308452
[TBL] [Abstract][Full Text] [Related]
9. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
[TBL] [Abstract][Full Text] [Related]
10. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
Prázný M
Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
[TBL] [Abstract][Full Text] [Related]
11. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.
Peyrot M; Barnett AH; Meneghini LF; Schumm-Draeger PM
Diabet Med; 2012 May; 29(5):682-9. PubMed ID: 22313123
[TBL] [Abstract][Full Text] [Related]
12. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
13. Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy.
Garnero TL; Davis NJ; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova JI; Peyrot M
Postgrad Med; 2018 May; 130(4):394-401. PubMed ID: 29571275
[TBL] [Abstract][Full Text] [Related]
14. Non-adherence to basal insulin among patients with type 2 diabetes in a US managed care population: Results from a patient survey.
Stephenson JJ; Raval AD; Kern DM; Bae JP
Diabetes Obes Metab; 2018 Nov; 20(11):2700-2704. PubMed ID: 29931727
[TBL] [Abstract][Full Text] [Related]
15. Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: A cross-sectional survey study.
Van Brunt K; Pedersini R; Rooney J; Corrigan SM
Diabetes Res Clin Pract; 2017 Apr; 126():30-42. PubMed ID: 28189952
[TBL] [Abstract][Full Text] [Related]
16. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
17. Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes.
Buysman E; Conner C; Aagren M; Bouchard J; Liu F
Curr Med Res Opin; 2011 Sep; 27(9):1709-17. PubMed ID: 21740289
[TBL] [Abstract][Full Text] [Related]
18. The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectives.
Ceriello A; deValk HW; Guerci B; Haak T; Owens D; Canobbio M; Fritzen K; Stautner C; Schnell O
Diabetes Res Clin Pract; 2020 Mar; 161():108053. PubMed ID: 32035117
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with reluctance to initiate or continue oral antihyperglycemic agent (OAHA) treatments in type 2 diabetes mellitus patients in Japan: An observational patient-reported study.
Kubo T; Okuyama K; Zhao X; Singh SS; Tokita S
Diabetes Metab Syndr; 2019; 13(2):1201-1207. PubMed ID: 31336465
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.
Dalal MR; Kazemi M; Ye F; Xie L
Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
